How 'time toxicity' impacts cancer patients; Harnessing immune diversity to treat deadly cancers

Time toxicity considers how much of a cancer patient's extended lifespan, in terms of survival, will be spent in related medical care.

April 11, 2023 Check out STAT+

Sponsored By

Caroline Yang for STAT Here's a new data point for cancer patients to consider: 'time toxicity' Some researchers say treatment studies should calculate how much of a patient's additional survival time would be spent simply getting care. By Charlotte Huff STAT+ | A biotech upstart takes on cancer by crowdsourcing the immune system's natural killers The Bay Area biotech believes it can harness the diversity of the immune system to treat a range of deadly cancers. By Jonathan Wosen STAT+ | Liver disease researchers are hoping AI can improve their trial design NASH and liver fibrosis are driven by a "multi-modal conspiracy"; the hope is that tools like ChatGPT can see patterns a human would miss. By Isabella Cueto

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Cancer Briefing? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2023, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser